Use Of Intramolecular 1,5-Sulfur-Oxygen And 1,5-Sulfur-Halogen Interactions In The Design Of N-Methyl-5-Aryl-N-(2,2,6,6-Tetramethylpiperidin-4-Yl)-1,3,4-Thiadiazol-2 -Amine Smn2 Splicing Modulators

Spinal muscular atrophy (SMA) is a debilitating neuromuscular disease caused by low levels of functional survival motor neuron protein (SMN) resulting from a deletion or loss of function mutation of the survival motor neuron 1 (SMN1) gene. Branaplam (1) elevates levels of full-length SMN protein in vivo by modulating the splicing of the related gene SMN2 to enhance the exon-7 inclusion and increase levels of the SMN. The intramolecular hydrogen bond present in the 2-hydroxyphenyl pyridazine core of 1 enforces a planar conformation of the biaryl system and is critical for the compound activity. Scaffold morphing revealed that the pyridazine could be replaced by a 1,3,4-thiadiazole, which provided additional opportunities for a conformational constraint of the biaryl through intramolecular 1,5-sulfur-oxygen (S center dot center dot center dot O) or 1,5-sulfur-halogen (S center dot center dot center dot X) noncovalent interactions. Compound 26, which incorporates a 2-fluorophenyl thiadiazole motif, demonstrated a greater than 50% increase in production of full-length SMN protein in a mouse model of SMA.